» Articles » PMID: 17086362

Association of High-density Lipoprotein Levels and Carotid Atherosclerotic Plaque Characteristics by Magnetic Resonance Imaging

Overview
Publisher Springer
Specialty Radiology
Date 2006 Nov 7
PMID 17086362
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A low level of high-density lipoprotein cholesterol (HDL-C) is a risk factor for atherosclerotic disease. Magnetic resonance imaging (MRI) can provide detailed information on carotid atherosclerotic plaque size and composition. The purpose of this study was to correlate HDL levels with carotid plaque burden and composition by MRI. Thirty-four patients with coronary artery disease (CAD) receiving simvastatin plus niacin or placebo for both drugs for three years were randomly selected to undergo MRI of carotid arteries. Atherosclerotic plaque wall volumes (WVs) and plaque components including lipid rich/necrotic core (LR/NC), calcium, fibrous tissue, and loose matrix were measured. Mean WV or atherosclerotic burden was significantly associated with total HDL-C levels (r = -0.39, P = 0.02), HDL(2) (r = -0.36, P = 0.03), HDL(3) (r = -0.34, P = 0.04), and LDL/HDL ratio (r = 0.42, P = 0.02). Plaque lipid composition or LR/NC was significantly associated with HDL(3) (r = -0.68, P = 0.02). Patients with low HDL levels (<or=35 mg/dL) had increased WV (97 +/- 23 vs. 81 +/- 19 mm(3), P = 0.05) compared with patients with HDL levels > 35 mg/dL. Among CAD patients, low HDL-C levels were significantly associated with increased carotid atherosclerotic plaque burden and lipid content by MRI.

Citing Articles

Combined spatiotemporal and frequency-dependent shear wave elastography enables detection of vulnerable carotid plaques as validated by MRI.

Marlevi D, Mulvagh S, Huang R, DeMarco J, Ota H, Huston 3rd J Sci Rep. 2020; 10(1):403.

PMID: 31942025 PMC: 6962347. DOI: 10.1038/s41598-019-57317-7.


Clinical factors associated with high-risk carotid plaque features as assessed by magnetic resonance imaging in patients with established vascular disease (from the AIM-HIGH Study).

Zhao X, Hatsukami T, Hippe D, Sun J, Balu N, Isquith D Am J Cardiol. 2014; 114(9):1412-9.

PMID: 25245415 PMC: 4195846. DOI: 10.1016/j.amjcard.2014.08.001.


High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study.

Tiozzo E, Gardener H, Hudson B, Dong C, Della-Morte D, Crisby M Atherosclerosis. 2014; 237(1):163-8.

PMID: 25240111 PMC: 4890152. DOI: 10.1016/j.atherosclerosis.2014.09.002.


Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.

Zhao X, Kerwin W Clin Lipidol. 2012; 7(3):329-343.

PMID: 23197995 PMC: 3506125. DOI: 10.2217/clp.12.33.


Predictive value of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for the prevention of stroke recurrence in Japanese patients treated with rosuvastatin.

Igase M, Kohara K, Katagi R, Yamashita S, Fujisawa M, Miki T Clin Drug Investig. 2012; 32(8):513-21.

PMID: 22741749 DOI: 10.1007/BF03261902.


References
1.
Zhao X, Yuan C, Hatsukami T, Frechette E, Kang X, Maravilla K . Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol. 2001; 21(10):1623-9. DOI: 10.1161/hq1001.098463. View

2.
Gordon D, Probstfield J, Garrison R, Neaton J, CASTELLI W, Knoke J . High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989; 79(1):8-15. DOI: 10.1161/01.cir.79.1.8. View

3.
Pulido M, Angiolillo D, Costa M . Imaging of atherosclerotic plaque. Int J Cardiovasc Imaging. 2005; 20(6):553-9. DOI: 10.1007/s10554-004-7019-x. View

4.
Skinner M, Yuan C, Mitsumori L, Hayes C, Raines E, Nelson J . Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. 1995; 1(1):69-73. DOI: 10.1038/nm0195-69. View

5.
Tanne D, Yaari S, Goldbourt U . High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke. 1997; 28(1):83-7. DOI: 10.1161/01.str.28.1.83. View